RGNX — Regenxbio Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapSucker Stock

Annual balance sheet for Regenxbio, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	457	365	275	235	230
Net Total Accounts Receivable
Net Total Receivables	32.4	28.1	24.8	20.5	38.3
Prepaid Expenses
Total Other Current Assets
Total Current Assets	519	416	335	278	281
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	192	207	193	171	152
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	1,114	833	574	466	453
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	130	130	130	103	118
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	350	317	262	206	350
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	764	516	312	260	103
Total Liabilities & Shareholders' Equity	1,114	833	574	466	453
Total Common Shares Outstanding